998 related articles for article (PubMed ID: 29176845)
1. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
Basila M; Kelley ML; Smith AVB
PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
[TBL] [Abstract][Full Text] [Related]
2. Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing.
Kelley ML; Strezoska Ž; He K; Vermeulen A; Smith Av
J Biotechnol; 2016 Sep; 233():74-83. PubMed ID: 27374403
[TBL] [Abstract][Full Text] [Related]
3. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
4. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
5. Conjugation and Evaluation of Triazole-Linked Single Guide RNA for CRISPR-Cas9 Gene Editing.
He K; Chou ET; Begay S; Anderson EM; van Brabant Smith A
Chembiochem; 2016 Oct; 17(19):1809-1812. PubMed ID: 27441384
[TBL] [Abstract][Full Text] [Related]
6. Improving Stability and Specificity of CRISPR/Cas9 System by Selective Modification of Guide RNAs with 2'-fluoro and Locked Nucleic Acid Nucleotides.
Sakovina L; Vokhtantsev I; Vorobyeva M; Vorobyev P; Novopashina D
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362256
[TBL] [Abstract][Full Text] [Related]
7. One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs.
Hirata M; Wittayarat M; Tanihara F; Sato Y; Namula Z; Le QA; Lin Q; Takebayashi K; Otoi T
In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):614-621. PubMed ID: 32978715
[TBL] [Abstract][Full Text] [Related]
8. Chemical Modification of CRISPR
Schubert MS; Cedrone E; Neun B; Behlke MA; Dobrovolskaia MA
J Cytokine Biol; 2018; 3(1):. PubMed ID: 30225466
[TBL] [Abstract][Full Text] [Related]
9. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
Peng Y; Yang T; Tang X; Chen F; Wang S
Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
[TBL] [Abstract][Full Text] [Related]
10. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
[TBL] [Abstract][Full Text] [Related]
11. Synthetic CRISPR RNA-Cas9-guided genome editing in human cells.
Rahdar M; McMahon MA; Prakash TP; Swayze EE; Bennett CF; Cleveland DW
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7110-7. PubMed ID: 26589814
[TBL] [Abstract][Full Text] [Related]
12. Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish.
Kotani H; Taimatsu K; Ohga R; Ota S; Kawahara A
PLoS One; 2015; 10(5):e0128319. PubMed ID: 26010089
[TBL] [Abstract][Full Text] [Related]
13. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
Kumar R; Tiwari K; Saudagar P
Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
[TBL] [Abstract][Full Text] [Related]
14. Key sequence features of CRISPR RNA for dual-guide CRISPR-Cas9 ribonucleoprotein complexes assembled with wild-type or HiFi Cas9.
Okada K; Aoki K; Tabei T; Sugio K; Imai K; Bonkohara Y; Kamachi Y
Nucleic Acids Res; 2022 Mar; 50(5):2854-2871. PubMed ID: 35166844
[TBL] [Abstract][Full Text] [Related]
15. Phosphonoacetate Modifications Enhance the Stability and Editing Yields of Guide RNAs for Cas9 Editors.
Ryan DE; Diamant-Levi T; Steinfeld I; Taussig D; Visal-Shah S; Thakker S; Lunstad BD; Kaiser RJ; McCaffrey R; Ortiz M; Townsend J; Welch WRW; Singh M; Curry B; Dellinger DJ; Bruhn L
Biochemistry; 2023 Dec; 62(24):3512-3520. PubMed ID: 35436085
[TBL] [Abstract][Full Text] [Related]
16. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Efficient Gene Deletion by CRISPR/Cas9.
Neldeborg S; Lin L; Stougaard M; Luo Y
Methods Mol Biol; 2019; 1961():233-247. PubMed ID: 30912049
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis.
Wang Y; Peng Y; Zi G; Chen J; Peng B
Sci Rep; 2024 Apr; 14(1):8095. PubMed ID: 38582932
[TBL] [Abstract][Full Text] [Related]
19. Electroporation-Based CRISPR/Cas9 Gene Editing Using Cas9 Protein and Chemically Modified sgRNAs.
Laustsen A; Bak RO
Methods Mol Biol; 2019; 1961():127-134. PubMed ID: 30912044
[TBL] [Abstract][Full Text] [Related]
20. Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays.
Kurata M; Wolf NK; Lahr WS; Weg MT; Kluesner MG; Lee S; Hui K; Shiraiwa M; Webber BR; Moriarity BS
PLoS One; 2018; 13(9):e0198714. PubMed ID: 30222773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
